• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    CDMOs in the Spotlight: Investing in Themselves

    Extrusion-Spheronization in OSD Manufacturing

    Modernizing Therapeutic Cell Production

    Don’t Panic! A Toxicologist’s View on Proceeding After a Clinical Hold

    Digital Transformation in Pharma
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    ValiRx Signs Lease Deal with Nottingham Laboratories

    Civica Partners with Ypsomed for Insulin Injection Pen

    Charles River Laboratories Completes the Acquisition of SAMDI Tech

    Selkirk Pharma Names New Director for Business Development

    Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing

    Upsher-Smith Opens State-of-the-Art Manufacturing Facility

    Elektrofi, Thermo Fisher Enter Strategic Contract Manufacturing Pact

    Societal CDMO Signs More Than $6M in Work Orders During 4Q22

    Genenta Science, AGC Biologics Enter Development and Manufacturing Service Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Upsher-Smith Opens State-of-the-Art Manufacturing Facility

    Beat the Supply Chain Backlog

    HPNE Launches Innovative Single-Use Assembly Service

    CDMO Selection and Tech Transfer – An Insider’s Guide to Injectables Excellence

    Catalent Bolsters Cell and Gene Services
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    ValiRx Signs Lease Deal with Nottingham Laboratories

    Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing

    Genenta Science, AGC Biologics Enter Development and Manufacturing Service Pact

    Baby Steps Toward the 21st Century

    Modernizing Therapeutic Cell Production
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Don’t Panic! A Toxicologist’s View on Proceeding After a Clinical Hold

    People and Culture Drive Operational Excellence

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    CMC Pharmaceuticals

    Almac Group

    Syngene International Ltd.

    Chiron Recombinant Proteins
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    CMC Pharmaceuticals

    Almac Group

    Syngene International Ltd.

    Chiron Recombinant Proteins
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Xencor, Genentech Enter Research & Licensing Deal

    To develop and commercialize Novel IL-15 Immune Activating Cytokines

    Related Content
    • argenx and Halozyme Announce License Agreement
    • AI in Pharma: Transforming Data into Drugs
    • United Therapeutics Completes Ralinepag License Agreement
    • Philogen Ties-up with Big Pharma
    • Rigel, Grifols Enter License Agreement
    02.05.19
    Xencor, Inc. has entered into a research and license agreement with Genentech, a member of the Roche Group, to develop and commercialize novel IL-15 cytokine therapeutics, including XmAb®24306. XmAb24306 is an IL-15/IL-15Rα cytokine complex engineered with Xencor's bispecific Fc domain and Xtend Fc technology and is Xencor's most advanced preclinical cytokine program.

    "This partnership with Genentech accelerates our immuno-oncology work by enabling the exploration of novel XmAb24306 combinations with Genentech's leading oncology portfolio and our growing internal pipeline of bispecific antibodies," said Bassil Dahiyat, Ph.D., president and chief executive officer at Xencor. "A wide-ranging combination strategy will be critical to realize the potential of IL-15 bispecific cytokines such as XmAb24306, so we plan to explore our cytokines with a broad spectrum of leading commercial-stage and investigational cancer therapies."

    "We believe cytokine therapy will play an important role in the treatment of a wide range of diseases, including cancer," said James Sabry, M.D., Ph.D., global head of Pharma Partnering, Roche. "This collaboration with Xencor will further enhance our understanding of a critical immune activation pathway and may present a potential new way to use the immune system to target cancer." 

    IL-15 is a highly active cytokine, or immune signaling protein, that when pre-complexed with IL-15 receptor alpha (IL-15Rα) will bind to IL-15Rβγ and stimulate the expansion and activation of natural killer (NK) cells and cytotoxic T cells, but with reduced regulatory T cell activation compared to IL-2. Xencor's IL-15 bispecific cytokine platform provides a more druggable version of IL-15 with potentially superior tolerability, slower receptor-mediated clearance and a prolonged half-life, and is intended for development with a wide range of combination agents due to its proposed mechanism of activating tumor-killing immune cells.

    Under the terms of the agreement, the companies will co-develop XmAb24306 and other potential IL-15 programs, in which the companies will share development costs and profits. Genentech will commercialize medicines worldwide, and Xencor has the option to co-promote in the United States. Additionally, the companies will engage in a two-year research program to discover new IL-15 drug candidates, including ones targeted to specific immune cell populations. Genentech will pay Xencor $120 million upfront, and Xencor will be eligible to receive up to $160 million in development milestones for the XmAb24306 program and up to $180 million in development milestones for each new IL-15 drug candidate.
     
    Related Searches
    • pipeline
    • Development
    • Pharma
    • license
    Suggested For You
    argenx and Halozyme Announce License Agreement argenx and Halozyme Announce License Agreement
    AI in Pharma: Transforming Data into Drugs AI in Pharma: Transforming Data into Drugs
    United Therapeutics Completes Ralinepag License Agreement United Therapeutics Completes Ralinepag License Agreement
    Philogen Ties-up with Big Pharma Philogen Ties-up with Big Pharma
    Rigel, Grifols Enter License Agreement Rigel, Grifols Enter License Agreement
    Bridge Bio, Daewoong Pharma to Develop New UC Treatment Bridge Bio, Daewoong Pharma to Develop New UC Treatment
    AC Immune & WuXi Biologics Enter Collaboration AC Immune & WuXi Biologics Enter Collaboration
    Proteostasis & Genentech Sign Licensing Deal Proteostasis & Genentech Sign Licensing Deal
    Orchard & SIRION Enter License Agreement Orchard & SIRION Enter License Agreement
    Entera & Amgen Sign Research Agreement Entera & Amgen Sign Research Agreement
    Executive Moves at Roche Executive Moves at Roche
    AI in Pharma: Transforming Data into Drugs AI in Pharma: Transforming Data into Drugs
    CBT, Bossan Enter Clinical Collaboration CBT, Bossan Enter Clinical Collaboration
    Immunocore, Genentech Expand Anti-Cancer Alliance Immunocore, Genentech Expand Anti-Cancer Alliance
    Genentech Genentech's XOFLUZA Wins FDA Approval

    Related Breaking News

    • argenx and Halozyme Announce License Agreement

      argenx and Halozyme Announce License Agreement

      argenx gains use of Halozyme’s ENHANZE drug delivery technology to develop multiple subcutaneous product formulations for current or future argenx products
      02.04.19

    • AI in Pharma: Transforming Data into Drugs

      AI in Pharma: Transforming Data into Drugs

      Jane Z. Reed of Linguamatics discusses the potential benefits and obstacles leveraging data through AI
      Kristin Brooks, Contract Pharma 01.25.19

    • Breaking News | cGMP Manufacture | Drug Development | Industry News
      United Therapeutics Completes Ralinepag License Agreement

      United Therapeutics Completes Ralinepag License Agreement

      Gains exclusive rights to develop and manufacture Phase III candidate ralinepag for PAH
      01.25.19


    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Philogen Ties-up with Big Pharma

      Philogen Ties-up with Big Pharma

      Italy-based biotech forms discovery collaborations with J&J and Celgene
      01.24.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      Rigel, Grifols Enter License Agreement

      Rigel, Grifols Enter License Agreement

      To commercialize fostamatinib disodium hexahydrate in all potential indications in Europe and Turkey
      01.23.19

    Loading, Please Wait..
    Trending
    • Steriline Provides Fill-Finish Solution For Berkshire Sterile Manufacturing
    • Thermo Fisher, Celltrio Partner On Cell Line Automation Platform
    • Bristol Myers Squibb 4Q Results
    • Astellas Announces New President And CEO And Management Structure
    • Bionova Expansion Project To Quadruple GMP Biologics Manufacturing Capacity
    Breaking News
    • ValiRx Signs Lease Deal with Nottingham Laboratories
    • Civica Partners with Ypsomed for Insulin Injection Pen
    • Charles River Laboratories Completes the Acquisition of SAMDI Tech
    • Selkirk Pharma Names New Director for Business Development
    • Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing
    View Breaking News >
    CURRENT ISSUE

    January/February 2023

    • CDMOs in the Spotlight: Investing in Themselves
    • Extrusion-Spheronization in OSD Manufacturing
    • Modernizing Therapeutic Cell Production
    • Don’t Panic! A Toxicologist’s View on Proceeding After a Clinical Hold
    • Digital Transformation in Pharma
    • Fill-Finish in Cell & Gene Therapy
    • Early-Stage Biotechs: What’s Essential and What’s Not
    • Five Insights to Maximize Customer-Centric Acquisition Growth
    • Challenges in API Technical Transfer
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    ADM Expands Production to Meet Demand for Probiotics
    Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA
    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder
    Coatings World

    Latest Breaking News From Coatings World

    Personnel Changes at BASF
    Dr. Kurt Wood to Deliver Mattiello Memorial Lecture at ACA’s 2023 CoatingsTech Conference
    hubergroup Chemicals to Debut at the European Coatings Show
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Konica Minolta Introduces Mobile X-Ray Systems to Latin America
    NIH MedTech Program Aims to Develop Neurological Treatment Tech
    Formula Plastics Appoints Bill Gerard as President
    Contract Pharma

    Latest Breaking News From Contract Pharma

    ValiRx Signs Lease Deal with Nottingham Laboratories
    Civica Partners with Ypsomed for Insulin Injection Pen
    Charles River Laboratories Completes the Acquisition of SAMDI Tech
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Tree Hut Introduces Body Wash Line
    Zara Introduces Mini Artists—Beauty Products for Kids
    L’Oréal USA Taps Stephanie Kramer as Chief Human Resources Officer
    Happi

    Latest Breaking News From Happi

    FTC Extends Public Comment Period on Potential Updates to Green Guides
    Arm & Hammer Taps Dave & Jenny Marrs, TikTokers for Budget-Centered 'Give It The Hammer' Campaign
    Meaningful Beauty Age-Proof Hair Care System Now Available on Amazon
    Ink World

    Latest Breaking News From Ink World

    Siegwerk, Wildplastic, TU-Hamburg Partner on Deinking
    Brilliant Group and Terra Firm Launch Partnership
    hubergroup Chemicals Debuts at the European Coatings Show
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    The Oldham Group names Doug McClure technical sales rep
    Siegwerk partnership aims to improve plastic waste recyclability
    CELAB-Europe launches new web hub for liner recyclers
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Hospeco Offers TaskBrand Prep-Paint-Finish Wiping System
    Toray to Expand PPS Production in Korea
    Masque Bar Launches Compostable Sheet Masks
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OSSIO Introduces Non-Permanent Compression Staple
    Dennis Jones Joins Intelivation Technologies as Manufacturing VP
    Jury Convicts Chiropractor, Orthopedic Surgeon in $31M Fraud Scheme
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Technologies Extends Partnership with the NFL
    OE-A at LOPEC – Printed Electronics Up Close
    Monthly Recap: LG OLED, Avery Dennison and JOLED Top This Month’s Stories

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login